The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Iakovleva E.V.

Gematologicheskiĭ nauchnyĭ tsentr Minzdrava Rossii, Moskva

Surin V.L.

National Research Centre for Hematology, Ministry of Health of Russia, Moscow, Russia

Selivanova D.S.

National Research Center for Hematology, Ministry of Health of Russia, Moscow, Russia

Sergeeva A.M.

National Research Center for Hematology, Ministry of Health of Russia, Moscow, Russia

Goncharova M.V.

OBUZ "Gorodskaia klinicheskaia bol'nitsa #25", Novosibirsk

Demidova E.Yu.

National Research Center for Hematology, Ministry of Health of Russia, Moscow, Russia

Soboleva N.P.

Federal Research Institute for Health Organization and Informatics, Ministry of Health of the Russia, 11, Dobrolyubov St., Moscow, Russia, 127254

Makhinia S.A.

Gematologicheskiĭ nauchnyĭ tsentr Minzdrava Rossii

Dezhenkova A.V.

National Research Center for Hematology, Ministry of Health of Russia, Moscow, Russia

Likhacheva E.A.

National Research Center for Hematology, Ministry of Health of Russia, Moscow, Russia

Zozulya N.I.

National Research Center for Hematology, Ministry of Health of Russia, Moscow, Russia

Hereditary afibrinogenemia: A literature review and clinical observations

Authors:

Iakovleva E.V., Surin V.L., Selivanova D.S., Sergeeva A.M., Goncharova M.V., Demidova E.Yu., Soboleva N.P., Makhinia S.A., Dezhenkova A.V., Likhacheva E.A., Zozulya N.I.

More about the authors

Journal: Therapeutic Archive. 2016;88(12): 120‑125

Read: 4375 times


To cite this article:

Iakovleva EV, Surin VL, Selivanova DS, et al. . Hereditary afibrinogenemia: A literature review and clinical observations. Therapeutic Archive. 2016;88(12):120‑125. (In Russ.)
https://doi.org/10.17116/terarkh20168812120-125

References:

  1. Peyvandi F. Result of an international, multicenter pharmacokinetic trial in congential fibrinogen deficiency. Thrombosis research. 2009;124(2):9-11. doi:10.1016/S0049-3848(09)70158-6
  2. Acharya S, Dimichele DM. Rare inherited disorders of fibrinogen. Haemophilia. 2008;14:1151-1158. doi:10.1111/j.1365-2516.2008.01831.x
  3. Peyvandi F, Moerloose P. Rare bleeding disorders. Haemophilia. 2012;18(4): 148-153. doi: 10.1111/j.1365-2516.2012.02841.x
  4. Bevan D. Cryoprecipitate: no longer the best therapeutic choice in congential fibrinogen disorders? Thrombosis research. 2009;124(2):12-15. doi:10.1016/S0049-3848(09)70159-8
  5. Sumitha E, Jayandharan N, Arora N, Abraham A, David S. Molecular basis of quantitative fibrinogen disorders in 27 patients from India. Haemophilia. 2013;19:611-618. doi: 10.1111/hae.12143
  6. Castman G, Rimoldi V, Giacomelli S, Duga S. Congential hypofibrinogenemia associated with novel homozygous fibrinogen Aα and Bβ chain mutations. Thrombosis research. 2015;136(1):144-147. doi:10.1016/j.thromres.2015.04.025
  7. Duga S, Asselta R, Santagostino E, Zeinali S, Simonic T, Malcovati M, Mannucci M, Tenchini M. Missense mutations in the human β fibrinogen gene cause congential afibrinogenemia by imparing fibrinogen secretion. Blood. 2000;95:1336-1341.
  8. Hariharan G, Ramachandran S, Parapurath R. Congential afibrinogenemia presenting as antenatal intracranial bleed: a case report. Journal of Pediatrics. 2010;36:1. doi:10.1186/1824-7288-36-1
  9. Shetty S, Shelar T, Mirgal D, Nawadkar V, Pinto P, Shabhag S, Mukaddam A, Kulkarni B, Ghosh K. Rare coagulation factor deficiencies: a countrywide screening data from India. Haemophilia. 2014;20:575-581. doi: 10.1111/hae.12368
  10. Stanciakova L, Kubisz P, Dobrotova M, Stasko J. Congenital afibrinogenemia: from etiopathogenesis to challenging clinical management. Expert Rev Hematol. 2016; 9(7):639-648. doi: 10.1080/17474086.2016.1200967
  11. Tziomalos K, Vakalopoulou S, Perifanis V, Garipidou V. Treatment of congential fibrinogen deficiency: overview and recent findings. Vasc Health Risk Manag. 2009;5:843-848. doi:10.2147/VHRM.S5305
  12. Gallastegui N, Kimble EL, Harrington TJ. Resolution of fibrinogen deficiency in patient with congenital afibrinogenemia after liver transplantation. Haemophilia. 2016;22(1):48-51. doi: 10.1111/hae.12802
  13. Sartori MT, Milan M, de Bon E, Fadin M, Pesavento R, Zanon E. Thrombosis of abdominal aorta in congenital afibrinogenemia: case report and review of literature. Haemophilia. 2015;21(1):88-94. doi: 10.1111/hae.12507
  14. Takasugi Y, Shiokawa Y, Kajikawa R, Oh J, Yamamoto Y, Sakata I, Koga Y. Mesenteric venous thrombosis in patient with congential afibrinogenemia and diffuse peritonitis. Ann Hematol. 2005;84(2):129-130. doi: 10.1007/s00277-004-0958-4
  15. Simsek I, de Mazancourt P, Horellou MH, Erdem H, Pay S, Dinc A, Samama MM.Afibrinogenemia resulting from homozygous nonsense mutation in A alpha chain gene associated with multiple thrombotic episodes. Blood Coagul Fibrinolysis. 2008;19(3):247-253. doi: 10.1097/MBC.0b013e3282f564fd
  16. Dupuy E, Soria C, Molho P, Zini JM, Rosenstingl S, Laurian C, Bruneval P, Tobelem G. Embolized ischemic lesions of toes in an afibrinogenemic patient: possible relevance to in vivo circulating thrombin. Thromb Res. 2001;102(3):211-219.
  17. Mosesson MW. Update on antithrombin I (fibrin). Thromb Haemost. 2007;98(1):105-108.
  18. Heyu Ni, Cécile V. Denis, Sangeetha Subbarao, Jay L. Degen, Thomas N. Sato, Richard O. Hynes, Denisa D. Wagner. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest. 2000;106(3):385-392. doi: 10.1172/JCI9896
  19. Neerman-Arbez M, de Moerloose P, Honsberger A, Parlier G, Arnuti B, Biron C, Borg JY, Eber S, Meili E, Peter-Salonen K, Ripoll L, Vervel C, d’Oiron R, Staeger P, Antonarakis SE, Morris MA. Molecular analysis of the fibrinogen gene cluster in 16 patients with congenital fibrinogenemia: novel truncating mutations in the FGA and FGG genes. Human Genetics. 2001;108(3):237-240. doi:10.1007/s004390100469
  20. Lombardi AM, Bortoletto E, Scarparo P, Scapin M, Santarossa L, Girolami A. Genetic study in patients with factor XII deficiency: a report of three new mutations exon 13 (Q501STOP), exon 14 (P547L) and -13C>T promoter region in three compound heterozygotes. Blood Coagul Fibrinolysis. 2008;19(7):639-643. doi: 10.1097/MBC.0b013e32830d8629

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.